The epidemiology of mumps in Italy

G. Gabutti, M. Guido, M. C. Rota, A. De Donno, M. L. Ciofi degli Atti, P. Crovari, D. Bassetti, A. Bechini, S. Boccalini, P. Bonanni, P. Caciagli, A. Camper, A. M. Campa, W. Caraccio, A. Cavallaro, E. Ciamarra, L. Clerico, L. Casentino, E. de Simone, A. FaveroA. Focà, L. Genna, A. Giammanco, A. Giancotti, A. Goglio, S. Grandesso, G. C. Icardi, C. Lolli, D. Marchetti, M. Marsella, P. Martelli, L. Mucignat, D. Palladino, C. Passerini, V. Perani, E. Piscione, F. Rizza, A. Zizza, L. Simula, R. Sforza, D. Tagliatatela, M. Tronci, D. Villalta

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In Italy, although vaccination has been recommended for a number of years, vaccination coverage for mumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence of mumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportion of individuals positive for mumps antibodies remained stable in the age classes 0-11 months and 1 year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. The percentage of susceptible individuals was higher than 20% in persons 2-14 years of age and exceeded 10% in persons 15-39 years of age. No statistically significant differences were observed by gender or geographical area. Comparison between these results and the data obtained from a 1996 survey showed a statistically significant increase in seroprevalence in the age class 2-4 years. No changes were observed in the other age-groups. The results of this study confirm that the efforts made in recent years to improve vaccination coverage within the second year of life should be strengthened.

Original languageEnglish
Pages (from-to)2906-2911
Number of pages6
JournalVaccine
Volume26
Issue number23
DOIs
Publication statusPublished - Jun 2 2008

Fingerprint

Mumps
Italy
epidemiology
Vaccination
Epidemiology
Seroepidemiologic Studies
vaccination
seroprevalence
age structure
Antibodies
antibodies
gender
Age Groups
Population

Keywords

  • Mumps
  • Seroprevalence
  • Vaccination

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Gabutti, G., Guido, M., Rota, M. C., De Donno, A., Ciofi degli Atti, M. L., Crovari, P., ... Villalta, D. (2008). The epidemiology of mumps in Italy. Vaccine, 26(23), 2906-2911. https://doi.org/10.1016/j.vaccine.2008.03.040

The epidemiology of mumps in Italy. / Gabutti, G.; Guido, M.; Rota, M. C.; De Donno, A.; Ciofi degli Atti, M. L.; Crovari, P.; Bassetti, D.; Bechini, A.; Boccalini, S.; Bonanni, P.; Caciagli, P.; Camper, A.; Campa, A. M.; Caraccio, W.; Cavallaro, A.; Ciamarra, E.; Clerico, L.; Casentino, L.; de Simone, E.; Favero, A.; Focà, A.; Genna, L.; Giammanco, A.; Giancotti, A.; Goglio, A.; Grandesso, S.; Icardi, G. C.; Lolli, C.; Marchetti, D.; Marsella, M.; Martelli, P.; Mucignat, L.; Palladino, D.; Passerini, C.; Perani, V.; Piscione, E.; Rizza, F.; Zizza, A.; Simula, L.; Sforza, R.; Tagliatatela, D.; Tronci, M.; Villalta, D.

In: Vaccine, Vol. 26, No. 23, 02.06.2008, p. 2906-2911.

Research output: Contribution to journalArticle

Gabutti, G, Guido, M, Rota, MC, De Donno, A, Ciofi degli Atti, ML, Crovari, P, Bassetti, D, Bechini, A, Boccalini, S, Bonanni, P, Caciagli, P, Camper, A, Campa, AM, Caraccio, W, Cavallaro, A, Ciamarra, E, Clerico, L, Casentino, L, de Simone, E, Favero, A, Focà, A, Genna, L, Giammanco, A, Giancotti, A, Goglio, A, Grandesso, S, Icardi, GC, Lolli, C, Marchetti, D, Marsella, M, Martelli, P, Mucignat, L, Palladino, D, Passerini, C, Perani, V, Piscione, E, Rizza, F, Zizza, A, Simula, L, Sforza, R, Tagliatatela, D, Tronci, M & Villalta, D 2008, 'The epidemiology of mumps in Italy', Vaccine, vol. 26, no. 23, pp. 2906-2911. https://doi.org/10.1016/j.vaccine.2008.03.040
Gabutti G, Guido M, Rota MC, De Donno A, Ciofi degli Atti ML, Crovari P et al. The epidemiology of mumps in Italy. Vaccine. 2008 Jun 2;26(23):2906-2911. https://doi.org/10.1016/j.vaccine.2008.03.040
Gabutti, G. ; Guido, M. ; Rota, M. C. ; De Donno, A. ; Ciofi degli Atti, M. L. ; Crovari, P. ; Bassetti, D. ; Bechini, A. ; Boccalini, S. ; Bonanni, P. ; Caciagli, P. ; Camper, A. ; Campa, A. M. ; Caraccio, W. ; Cavallaro, A. ; Ciamarra, E. ; Clerico, L. ; Casentino, L. ; de Simone, E. ; Favero, A. ; Focà, A. ; Genna, L. ; Giammanco, A. ; Giancotti, A. ; Goglio, A. ; Grandesso, S. ; Icardi, G. C. ; Lolli, C. ; Marchetti, D. ; Marsella, M. ; Martelli, P. ; Mucignat, L. ; Palladino, D. ; Passerini, C. ; Perani, V. ; Piscione, E. ; Rizza, F. ; Zizza, A. ; Simula, L. ; Sforza, R. ; Tagliatatela, D. ; Tronci, M. ; Villalta, D. / The epidemiology of mumps in Italy. In: Vaccine. 2008 ; Vol. 26, No. 23. pp. 2906-2911.
@article{8165f032449a45f3abbf9495a809aecc,
title = "The epidemiology of mumps in Italy",
abstract = "In Italy, although vaccination has been recommended for a number of years, vaccination coverage for mumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence of mumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportion of individuals positive for mumps antibodies remained stable in the age classes 0-11 months and 1 year (25.4{\%} and 30.8{\%}, respectively) and showed a continuous increase after the second year of life. The percentage of susceptible individuals was higher than 20{\%} in persons 2-14 years of age and exceeded 10{\%} in persons 15-39 years of age. No statistically significant differences were observed by gender or geographical area. Comparison between these results and the data obtained from a 1996 survey showed a statistically significant increase in seroprevalence in the age class 2-4 years. No changes were observed in the other age-groups. The results of this study confirm that the efforts made in recent years to improve vaccination coverage within the second year of life should be strengthened.",
keywords = "Mumps, Seroprevalence, Vaccination",
author = "G. Gabutti and M. Guido and Rota, {M. C.} and {De Donno}, A. and {Ciofi degli Atti}, {M. L.} and P. Crovari and D. Bassetti and A. Bechini and S. Boccalini and P. Bonanni and P. Caciagli and A. Camper and Campa, {A. M.} and W. Caraccio and A. Cavallaro and E. Ciamarra and L. Clerico and L. Casentino and {de Simone}, E. and A. Favero and A. Foc{\`a} and L. Genna and A. Giammanco and A. Giancotti and A. Goglio and S. Grandesso and Icardi, {G. C.} and C. Lolli and D. Marchetti and M. Marsella and P. Martelli and L. Mucignat and D. Palladino and C. Passerini and V. Perani and E. Piscione and F. Rizza and A. Zizza and L. Simula and R. Sforza and D. Tagliatatela and M. Tronci and D. Villalta",
year = "2008",
month = "6",
day = "2",
doi = "10.1016/j.vaccine.2008.03.040",
language = "English",
volume = "26",
pages = "2906--2911",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "23",

}

TY - JOUR

T1 - The epidemiology of mumps in Italy

AU - Gabutti, G.

AU - Guido, M.

AU - Rota, M. C.

AU - De Donno, A.

AU - Ciofi degli Atti, M. L.

AU - Crovari, P.

AU - Bassetti, D.

AU - Bechini, A.

AU - Boccalini, S.

AU - Bonanni, P.

AU - Caciagli, P.

AU - Camper, A.

AU - Campa, A. M.

AU - Caraccio, W.

AU - Cavallaro, A.

AU - Ciamarra, E.

AU - Clerico, L.

AU - Casentino, L.

AU - de Simone, E.

AU - Favero, A.

AU - Focà, A.

AU - Genna, L.

AU - Giammanco, A.

AU - Giancotti, A.

AU - Goglio, A.

AU - Grandesso, S.

AU - Icardi, G. C.

AU - Lolli, C.

AU - Marchetti, D.

AU - Marsella, M.

AU - Martelli, P.

AU - Mucignat, L.

AU - Palladino, D.

AU - Passerini, C.

AU - Perani, V.

AU - Piscione, E.

AU - Rizza, F.

AU - Zizza, A.

AU - Simula, L.

AU - Sforza, R.

AU - Tagliatatela, D.

AU - Tronci, M.

AU - Villalta, D.

PY - 2008/6/2

Y1 - 2008/6/2

N2 - In Italy, although vaccination has been recommended for a number of years, vaccination coverage for mumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence of mumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportion of individuals positive for mumps antibodies remained stable in the age classes 0-11 months and 1 year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. The percentage of susceptible individuals was higher than 20% in persons 2-14 years of age and exceeded 10% in persons 15-39 years of age. No statistically significant differences were observed by gender or geographical area. Comparison between these results and the data obtained from a 1996 survey showed a statistically significant increase in seroprevalence in the age class 2-4 years. No changes were observed in the other age-groups. The results of this study confirm that the efforts made in recent years to improve vaccination coverage within the second year of life should be strengthened.

AB - In Italy, although vaccination has been recommended for a number of years, vaccination coverage for mumps is still sub-optimal. The objective of the present study was to evaluate the seroprevalence of mumps antibodies in the Italian population, stratified by age, gender and geographical area. The proportion of individuals positive for mumps antibodies remained stable in the age classes 0-11 months and 1 year (25.4% and 30.8%, respectively) and showed a continuous increase after the second year of life. The percentage of susceptible individuals was higher than 20% in persons 2-14 years of age and exceeded 10% in persons 15-39 years of age. No statistically significant differences were observed by gender or geographical area. Comparison between these results and the data obtained from a 1996 survey showed a statistically significant increase in seroprevalence in the age class 2-4 years. No changes were observed in the other age-groups. The results of this study confirm that the efforts made in recent years to improve vaccination coverage within the second year of life should be strengthened.

KW - Mumps

KW - Seroprevalence

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=43249102344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249102344&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2008.03.040

DO - 10.1016/j.vaccine.2008.03.040

M3 - Article

C2 - 18439732

AN - SCOPUS:43249102344

VL - 26

SP - 2906

EP - 2911

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23

ER -